Decision analysis for the evaluation of diagnostic tests, prediction models, and molecular markers

American Statistician

Volumn 62, Issue 4, 2008, Pages 314-320

  Vickers, Andrew J ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Decision support techniques; Outcome assessment; Prognosis

Indexed keywords

EID: 55049116162     PISSN: 00031305     EISSN: None     Source Type: Journal    
DOI: 10.1198/000313008X370302     Document Type: Article

References (11)

1. Baker S. G., and Kramer, B. (2007), "Peirce, Youden, and Receiver Operating Characteristic Curves," The American Statistician, 6, 1-4.
2. Berry, D. A., and Parmigiani, G. (1998), "Assessing the Benefits of Testing for Breast Cancer Susceptibility Genes: A Decision Analysis," Breast Disease, 10, 115-125.
3. Hunink, M., Glasziou, P., and Siegel, J. (2001), Decision-Making in Health and Medicine: Integrating Evidence and Values, New York: Cambridge University Press.
4. Maichionni, L., Wilson, R.F., Wolff, A.C., Marinopoulos, S., Parmigiani, G., Bass, E.B., and Goodman, S.N. (2008), "Systematic Review: Gene Expression Profiling Assays in Early-Stage Breast Cancer," The Annals of Intern Medicine, 148, 358-369.
5. Pauker, S. G., and Kassirer, J. P. (1980), "The Threshold Approach to Clinical Decision Making," New England Journal of Medicine, 302, 1109-1117.
6. Roddam, A.W., Duffy, M.J., Hamdy, F.C., Ward, A.M., Patrick, J., Price, C.P., Rimmer, J., Sturgeon, C., White, P., and Allen, N.E. (2005), "Use of Prostate-Specific Antigen (PSA) Isoforms for the Detection of Prostate Cancer in Men with a PSA level of 2-10 ng/ml: Systematic Review and Meta-analysis," European Urology, 48, 386-399.
7. Schroder, F. H., Denis, L. J., Roobol, M., Nelen, V., Auvinen, A., Tammela, T., Villers, A., Rebillard, X., Ciatto, S., Zappa, M., Berenguer, A., Paez, A., Hugosson, J., Lodding, P., Recker, F., Kwiatkowski, M., and Kirkels, W. J. (2003), "The Story of the European Randomized Study of Screening for Prostate Cancer," BJU International, 92, Suppl 2, 1-13.
8. Skates, S.J., Xu, F.J., Yu, Y.H., Sjövall, K., Einhorn, N., Chang, Y., Bast, R.C. Jr., Knapp R.C. (1995), "Toward an Optimal Algorithm for Ovarian Cancer Screening with Longitudinal Tumor Markers," Cancer, 76(10 Suppl), 2004-2010.
9. Vergouwe, Y., Steyerberg, E. W., Eijkemans, M. J., and Habbema, J. D. (2002), "Validity of Prognostic Models: When is a Model Clinically Useful?" Seminars in Urologic Oncology, 20, 96-107.
10. Vickers, A., Jang, K., Sargent, D., Lilja, H., and Kattan, M. (2008), "A Systematic Review of Statistical Methods used in Molecular Marker Studies in Cancer," Cancer, 112(8), 1862-1868.
11. Vickers, A. J., and Elkin, E. B. (2006), "Decision Curve Analysis: A Novel Method for Evaluating Prediction Models," Medical Decision Making, 26, 565-574.